Effect of hypertension therapy with the angiotensin-converting enzyme inhibitor lisinopril on hyperandrogenism in women with polycystic ovary syndrome

By Hacihanefioglu B.   Somunkiran A.   Mahmutoglu I.   Sercelik A.   Toptani S.   Kervancioglu E.  

Fertility and Sterility, Vol. 77, Iss. 3, 2002-03 ,pp. : 526-528

Elsevier

Access to resources Recommend Favorite

Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome

By Kocak M.   Caliskan E.   Simsir C.   Haberal A.  

Fertility and Sterility, Vol. 77, Iss. 1, 2002-01 ,pp. : 101-106

Elsevier

Access to resources Recommend Favorite

Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome

By Glueck C.J.   Wang P.   Kobayashi S.   Phillips H.   Sieve-Smith L.  

Fertility and Sterility, Vol. 77, Iss. 3, 2002-03 ,pp. : 520-525

Elsevier

Access to resources Recommend Favorite

Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome

By Azziz R.   Ehrmann D.A.   Legro R.S.   Fereshetian A.G.   O'Keefe M.   Ghazzi M.N.   PCOS/Troglitazone Study Group  

Fertility and Sterility, Vol. 79, Iss. 4, 2003-04 ,pp. : 932-937

Elsevier

Access to resources Recommend Favorite

Correction of hyperinsulinemia in oligoovulatory women with clomiphene-resistant polycystic ovary syndrome: a review of therapeutic rationale and reproductive outcomes

By Sills E.S.   Perloe M.   Palermo G.D.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 91, Iss. 2, 2000-08 ,pp. : 135-141

Elsevier

Access to resources Recommend Favorite